Bristol-Myers Squibb

IRS: 220790350
BMY
Bristol-Myers Squibb

Bristol-Myers Squibb Co discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders.

Founded
1989 (32 years)
CEO
Giovanni Caforio
Investor RelationsSEC
Revenue
35 billion (2020)

Want to see more? Sign up!